Plain-English translation of NCT06382233 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research project is looking for early warning signs in blood and urine that could help doctors better diagnose and predict how a kidney condition called ureteropelvic junction obstruction (UPJO) will develop in young children. Right now, doctors rely mainly on imaging tests like ultrasounds to decide if surgery is needed, but these tests aren't always reliable. By studying blood and urine samples from babies with this condition, researchers hope to find biological markers that give a clearer picture of which children truly need surgery and which ones can be monitored safely.
UPJO—a narrowing where urine leaves the kidney—is the most common birth-related kidney problem in children and can lead to lasting kidney damage if missed. Current imaging methods have significant limitations in reliably identifying which babies need surgery, so many children undergo unnecessary follow-up testing or delayed care. This study exists to fill that gap by discovering biological clues in body fluids that could make diagnosis faster, more accurate, and less risky for children.
You likely qualify if…
You likely don't qualify if…
If your child qualifies, you will be asked to provide a blood sample and a urine sample, which researchers will analyze to look for biological markers of kidney disease. Your child will be compared to a control group of other young children undergoing unrelated surgery. The study does not involve giving any medication or performing experimental procedures—it is purely observational, focusing on understanding what biological signals might help doctors make better decisions about your child's care.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Italy